Linden Announces Minority Investment from Blue Owl’s GP Strategic Capital Platform and Lunate

Linden Capital Partners, a Chicago-based healthcare private equity firm, is pleased to announce a passive, minority investment from Blue Owl’s GP Strategic Capital platform and Lunate Capital via their joint venture. Founded in 2004, Linden Capital Partners (“Linden”) has grown to become one of the largest dedicated healthcare private equity firms in the US, through a model of partnership with management teams and a rigorous Value Creation Program. Linden has approximately $8.0 billion of regulatory assets under management and has invested in over 45 healthcare companies across more than 350 transactions. Linden invests in middle market platforms in the targeted sub-sectors of healthcare services, medical products, and specialty distribution.

Read the full article: Linden Announces Minority Investment from Blue Owl’s GP Strategic Capital Platform and Lunate //

Source: https://www.prnewswire.com/news-releases/linden-announces-minority-investment-from-blue-owls-gp-strategic-capital-platform-and-lunate-302156131.html

Scroll to Top